Global GABA Receptor Agonist Drug Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of GABA Receptor Agonist Drug will have significant change from previous year. According to our (LP Information) latest study, the global GABA Receptor Agonist Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global GABA Receptor Agonist Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States GABA Receptor Agonist Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global GABA Receptor Agonist Drug market, reaching US$ million by the year 2028. As for the Europe GABA Receptor Agonist Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main GABA Receptor Agonist Drug players cover Advicenne, AstraZeneca, Athena Drug Delivery Solutions, and Biocodex, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of GABA Receptor Agonist Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of GABA Receptor Agonist Drug will have significant change from previous year. According to our (LP Information) latest study, the global GABA Receptor Agonist Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global GABA Receptor Agonist Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States GABA Receptor Agonist Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global GABA Receptor Agonist Drug market, reaching US$ million by the year 2028. As for the Europe GABA Receptor Agonist Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main GABA Receptor Agonist Drug players cover Advicenne, AstraZeneca, Athena Drug Delivery Solutions, and Biocodex, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of GABA Receptor Agonist Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Bamaluzole
- Phenibut
- Baclofen
- Gaboxadol
- Klonopin (clonazepam)
- Tiagbine
- Attention Deficit Hyperactivity Disorder (ADHD)
- Psychiatric Disorders and Depression
- Alzheimer
- Epilepsy and Seizure
- Anxiety and Sleep Disorders
- Obesity and Alcoholism
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Advicenne
- AstraZeneca
- Athena Drug Delivery Solutions
- Biocodex
- Elan Corporation
- Eli Lilly and Company
- H.LundBeck, Merck and Co
- GlaxoSmithKline
- NovaDel Pharma
- Novartis
- OVATION Pharmaceuticals
- Osmotica Pharmaceutical
- Pfizer
- sanofi-aventis
- VIVUS
- XenoPort
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GABA Receptor Agonist Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for GABA Receptor Agonist Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for GABA Receptor Agonist Drug by Country/Region, 2017, 2022 & 2028
2.2 GABA Receptor Agonist Drug Segment by Type
2.2.1 Bamaluzole
2.2.2 Phenibut
2.2.3 Baclofen
2.2.4 Gaboxadol
2.2.5 Klonopin (clonazepam)
2.2.6 Tiagbine
2.3 GABA Receptor Agonist Drug Sales by Type
2.3.1 Global GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)
2.3.2 Global GABA Receptor Agonist Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global GABA Receptor Agonist Drug Sale Price by Type (2017-2022)
2.4 GABA Receptor Agonist Drug Segment by Application
2.4.1 Attention Deficit Hyperactivity Disorder (ADHD)
2.4.2 Psychiatric Disorders and Depression
2.4.3 Alzheimer
2.4.4 Epilepsy and Seizure
2.4.5 Anxiety and Sleep Disorders
2.4.6 Obesity and Alcoholism
2.5 GABA Receptor Agonist Drug Sales by Application
2.5.1 Global GABA Receptor Agonist Drug Sale Market Share by Application (2017-2022)
2.5.2 Global GABA Receptor Agonist Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global GABA Receptor Agonist Drug Sale Price by Application (2017-2022)
3 GLOBAL GABA RECEPTOR AGONIST DRUG BY COMPANY
3.1 Global GABA Receptor Agonist Drug Breakdown Data by Company
3.1.1 Global GABA Receptor Agonist Drug Annual Sales by Company (2020-2022)
3.1.2 Global GABA Receptor Agonist Drug Sales Market Share by Company (2020-2022)
3.2 Global GABA Receptor Agonist Drug Annual Revenue by Company (2020-2022)
3.2.1 Global GABA Receptor Agonist Drug Revenue by Company (2020-2022)
3.2.2 Global GABA Receptor Agonist Drug Revenue Market Share by Company (2020-2022)
3.3 Global GABA Receptor Agonist Drug Sale Price by Company
3.4 Key Manufacturers GABA Receptor Agonist Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GABA Receptor Agonist Drug Product Location Distribution
3.4.2 Players GABA Receptor Agonist Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GABA RECEPTOR AGONIST DRUG BY GEOGRAPHIC REGION
4.1 World Historic GABA Receptor Agonist Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global GABA Receptor Agonist Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global GABA Receptor Agonist Drug Annual Revenue by Geographic Region
4.2 World Historic GABA Receptor Agonist Drug Market Size by Country/Region (2017-2022)
4.2.1 Global GABA Receptor Agonist Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global GABA Receptor Agonist Drug Annual Revenue by Country/Region
4.3 Americas GABA Receptor Agonist Drug Sales Growth
4.4 APAC GABA Receptor Agonist Drug Sales Growth
4.5 Europe GABA Receptor Agonist Drug Sales Growth
4.6 Middle East & Africa GABA Receptor Agonist Drug Sales Growth
5 AMERICAS
5.1 Americas GABA Receptor Agonist Drug Sales by Country
5.1.1 Americas GABA Receptor Agonist Drug Sales by Country (2017-2022)
5.1.2 Americas GABA Receptor Agonist Drug Revenue by Country (2017-2022)
5.2 Americas GABA Receptor Agonist Drug Sales by Type
5.3 Americas GABA Receptor Agonist Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GABA Receptor Agonist Drug Sales by Region
6.1.1 APAC GABA Receptor Agonist Drug Sales by Region (2017-2022)
6.1.2 APAC GABA Receptor Agonist Drug Revenue by Region (2017-2022)
6.2 APAC GABA Receptor Agonist Drug Sales by Type
6.3 APAC GABA Receptor Agonist Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GABA Receptor Agonist Drug by Country
7.1.1 Europe GABA Receptor Agonist Drug Sales by Country (2017-2022)
7.1.2 Europe GABA Receptor Agonist Drug Revenue by Country (2017-2022)
7.2 Europe GABA Receptor Agonist Drug Sales by Type
7.3 Europe GABA Receptor Agonist Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GABA Receptor Agonist Drug by Country
8.1.1 Middle East & Africa GABA Receptor Agonist Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa GABA Receptor Agonist Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa GABA Receptor Agonist Drug Sales by Type
8.3 Middle East & Africa GABA Receptor Agonist Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GABA Receptor Agonist Drug
10.3 Manufacturing Process Analysis of GABA Receptor Agonist Drug
10.4 Industry Chain Structure of GABA Receptor Agonist Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GABA Receptor Agonist Drug Distributors
11.3 GABA Receptor Agonist Drug Customer
12 WORLD FORECAST REVIEW FOR GABA RECEPTOR AGONIST DRUG BY GEOGRAPHIC REGION
12.1 Global GABA Receptor Agonist Drug Market Size Forecast by Region
12.1.1 Global GABA Receptor Agonist Drug Forecast by Region (2023-2028)
12.1.2 Global GABA Receptor Agonist Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global GABA Receptor Agonist Drug Forecast by Type
12.7 Global GABA Receptor Agonist Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Advicenne
13.1.1 Advicenne Company Information
13.1.2 Advicenne GABA Receptor Agonist Drug Product Offered
13.1.3 Advicenne GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Advicenne Main Business Overview
13.1.5 Advicenne Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca GABA Receptor Agonist Drug Product Offered
13.2.3 AstraZeneca GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Athena Drug Delivery Solutions
13.3.1 Athena Drug Delivery Solutions Company Information
13.3.2 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Offered
13.3.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Athena Drug Delivery Solutions Main Business Overview
13.3.5 Athena Drug Delivery Solutions Latest Developments
13.4 Biocodex
13.4.1 Biocodex Company Information
13.4.2 Biocodex GABA Receptor Agonist Drug Product Offered
13.4.3 Biocodex GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Biocodex Main Business Overview
13.4.5 Biocodex Latest Developments
13.5 Elan Corporation
13.5.1 Elan Corporation Company Information
13.5.2 Elan Corporation GABA Receptor Agonist Drug Product Offered
13.5.3 Elan Corporation GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Elan Corporation Main Business Overview
13.5.5 Elan Corporation Latest Developments
13.6 Eli Lilly and Company
13.6.1 Eli Lilly and Company Company Information
13.6.2 Eli Lilly and Company GABA Receptor Agonist Drug Product Offered
13.6.3 Eli Lilly and Company GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Eli Lilly and Company Main Business Overview
13.6.5 Eli Lilly and Company Latest Developments
13.7 H.LundBeck, Merck and Co
13.7.1 H.LundBeck, Merck and Co Company Information
13.7.2 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product Offered
13.7.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 H.LundBeck, Merck and Co Main Business Overview
13.7.5 H.LundBeck, Merck and Co Latest Developments
13.8 GlaxoSmithKline
13.8.1 GlaxoSmithKline Company Information
13.8.2 GlaxoSmithKline GABA Receptor Agonist Drug Product Offered
13.8.3 GlaxoSmithKline GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GlaxoSmithKline Main Business Overview
13.8.5 GlaxoSmithKline Latest Developments
13.9 NovaDel Pharma
13.9.1 NovaDel Pharma Company Information
13.9.2 NovaDel Pharma GABA Receptor Agonist Drug Product Offered
13.9.3 NovaDel Pharma GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 NovaDel Pharma Main Business Overview
13.9.5 NovaDel Pharma Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis GABA Receptor Agonist Drug Product Offered
13.10.3 Novartis GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 OVATION Pharmaceuticals
13.11.1 OVATION Pharmaceuticals Company Information
13.11.2 OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Offered
13.11.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 OVATION Pharmaceuticals Main Business Overview
13.11.5 OVATION Pharmaceuticals Latest Developments
13.12 Osmotica Pharmaceutical
13.12.1 Osmotica Pharmaceutical Company Information
13.12.2 Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Offered
13.12.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Osmotica Pharmaceutical Main Business Overview
13.12.5 Osmotica Pharmaceutical Latest Developments
13.13 Pfizer
13.13.1 Pfizer Company Information
13.13.2 Pfizer GABA Receptor Agonist Drug Product Offered
13.13.3 Pfizer GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Pfizer Main Business Overview
13.13.5 Pfizer Latest Developments
13.14 sanofi-aventis
13.14.1 sanofi-aventis Company Information
13.14.2 sanofi-aventis GABA Receptor Agonist Drug Product Offered
13.14.3 sanofi-aventis GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 sanofi-aventis Main Business Overview
13.14.5 sanofi-aventis Latest Developments
13.15 VIVUS
13.15.1 VIVUS Company Information
13.15.2 VIVUS GABA Receptor Agonist Drug Product Offered
13.15.3 VIVUS GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 VIVUS Main Business Overview
13.15.5 VIVUS Latest Developments
13.16 XenoPort
13.16.1 XenoPort Company Information
13.16.2 XenoPort GABA Receptor Agonist Drug Product Offered
13.16.3 XenoPort GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 XenoPort Main Business Overview
13.16.5 XenoPort Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GABA Receptor Agonist Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for GABA Receptor Agonist Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for GABA Receptor Agonist Drug by Country/Region, 2017, 2022 & 2028
2.2 GABA Receptor Agonist Drug Segment by Type
2.2.1 Bamaluzole
2.2.2 Phenibut
2.2.3 Baclofen
2.2.4 Gaboxadol
2.2.5 Klonopin (clonazepam)
2.2.6 Tiagbine
2.3 GABA Receptor Agonist Drug Sales by Type
2.3.1 Global GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)
2.3.2 Global GABA Receptor Agonist Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global GABA Receptor Agonist Drug Sale Price by Type (2017-2022)
2.4 GABA Receptor Agonist Drug Segment by Application
2.4.1 Attention Deficit Hyperactivity Disorder (ADHD)
2.4.2 Psychiatric Disorders and Depression
2.4.3 Alzheimer
2.4.4 Epilepsy and Seizure
2.4.5 Anxiety and Sleep Disorders
2.4.6 Obesity and Alcoholism
2.5 GABA Receptor Agonist Drug Sales by Application
2.5.1 Global GABA Receptor Agonist Drug Sale Market Share by Application (2017-2022)
2.5.2 Global GABA Receptor Agonist Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global GABA Receptor Agonist Drug Sale Price by Application (2017-2022)
3 GLOBAL GABA RECEPTOR AGONIST DRUG BY COMPANY
3.1 Global GABA Receptor Agonist Drug Breakdown Data by Company
3.1.1 Global GABA Receptor Agonist Drug Annual Sales by Company (2020-2022)
3.1.2 Global GABA Receptor Agonist Drug Sales Market Share by Company (2020-2022)
3.2 Global GABA Receptor Agonist Drug Annual Revenue by Company (2020-2022)
3.2.1 Global GABA Receptor Agonist Drug Revenue by Company (2020-2022)
3.2.2 Global GABA Receptor Agonist Drug Revenue Market Share by Company (2020-2022)
3.3 Global GABA Receptor Agonist Drug Sale Price by Company
3.4 Key Manufacturers GABA Receptor Agonist Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GABA Receptor Agonist Drug Product Location Distribution
3.4.2 Players GABA Receptor Agonist Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GABA RECEPTOR AGONIST DRUG BY GEOGRAPHIC REGION
4.1 World Historic GABA Receptor Agonist Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global GABA Receptor Agonist Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global GABA Receptor Agonist Drug Annual Revenue by Geographic Region
4.2 World Historic GABA Receptor Agonist Drug Market Size by Country/Region (2017-2022)
4.2.1 Global GABA Receptor Agonist Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global GABA Receptor Agonist Drug Annual Revenue by Country/Region
4.3 Americas GABA Receptor Agonist Drug Sales Growth
4.4 APAC GABA Receptor Agonist Drug Sales Growth
4.5 Europe GABA Receptor Agonist Drug Sales Growth
4.6 Middle East & Africa GABA Receptor Agonist Drug Sales Growth
5 AMERICAS
5.1 Americas GABA Receptor Agonist Drug Sales by Country
5.1.1 Americas GABA Receptor Agonist Drug Sales by Country (2017-2022)
5.1.2 Americas GABA Receptor Agonist Drug Revenue by Country (2017-2022)
5.2 Americas GABA Receptor Agonist Drug Sales by Type
5.3 Americas GABA Receptor Agonist Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GABA Receptor Agonist Drug Sales by Region
6.1.1 APAC GABA Receptor Agonist Drug Sales by Region (2017-2022)
6.1.2 APAC GABA Receptor Agonist Drug Revenue by Region (2017-2022)
6.2 APAC GABA Receptor Agonist Drug Sales by Type
6.3 APAC GABA Receptor Agonist Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GABA Receptor Agonist Drug by Country
7.1.1 Europe GABA Receptor Agonist Drug Sales by Country (2017-2022)
7.1.2 Europe GABA Receptor Agonist Drug Revenue by Country (2017-2022)
7.2 Europe GABA Receptor Agonist Drug Sales by Type
7.3 Europe GABA Receptor Agonist Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GABA Receptor Agonist Drug by Country
8.1.1 Middle East & Africa GABA Receptor Agonist Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa GABA Receptor Agonist Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa GABA Receptor Agonist Drug Sales by Type
8.3 Middle East & Africa GABA Receptor Agonist Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GABA Receptor Agonist Drug
10.3 Manufacturing Process Analysis of GABA Receptor Agonist Drug
10.4 Industry Chain Structure of GABA Receptor Agonist Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GABA Receptor Agonist Drug Distributors
11.3 GABA Receptor Agonist Drug Customer
12 WORLD FORECAST REVIEW FOR GABA RECEPTOR AGONIST DRUG BY GEOGRAPHIC REGION
12.1 Global GABA Receptor Agonist Drug Market Size Forecast by Region
12.1.1 Global GABA Receptor Agonist Drug Forecast by Region (2023-2028)
12.1.2 Global GABA Receptor Agonist Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global GABA Receptor Agonist Drug Forecast by Type
12.7 Global GABA Receptor Agonist Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Advicenne
13.1.1 Advicenne Company Information
13.1.2 Advicenne GABA Receptor Agonist Drug Product Offered
13.1.3 Advicenne GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Advicenne Main Business Overview
13.1.5 Advicenne Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca GABA Receptor Agonist Drug Product Offered
13.2.3 AstraZeneca GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Athena Drug Delivery Solutions
13.3.1 Athena Drug Delivery Solutions Company Information
13.3.2 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Offered
13.3.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Athena Drug Delivery Solutions Main Business Overview
13.3.5 Athena Drug Delivery Solutions Latest Developments
13.4 Biocodex
13.4.1 Biocodex Company Information
13.4.2 Biocodex GABA Receptor Agonist Drug Product Offered
13.4.3 Biocodex GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Biocodex Main Business Overview
13.4.5 Biocodex Latest Developments
13.5 Elan Corporation
13.5.1 Elan Corporation Company Information
13.5.2 Elan Corporation GABA Receptor Agonist Drug Product Offered
13.5.3 Elan Corporation GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Elan Corporation Main Business Overview
13.5.5 Elan Corporation Latest Developments
13.6 Eli Lilly and Company
13.6.1 Eli Lilly and Company Company Information
13.6.2 Eli Lilly and Company GABA Receptor Agonist Drug Product Offered
13.6.3 Eli Lilly and Company GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Eli Lilly and Company Main Business Overview
13.6.5 Eli Lilly and Company Latest Developments
13.7 H.LundBeck, Merck and Co
13.7.1 H.LundBeck, Merck and Co Company Information
13.7.2 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product Offered
13.7.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 H.LundBeck, Merck and Co Main Business Overview
13.7.5 H.LundBeck, Merck and Co Latest Developments
13.8 GlaxoSmithKline
13.8.1 GlaxoSmithKline Company Information
13.8.2 GlaxoSmithKline GABA Receptor Agonist Drug Product Offered
13.8.3 GlaxoSmithKline GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GlaxoSmithKline Main Business Overview
13.8.5 GlaxoSmithKline Latest Developments
13.9 NovaDel Pharma
13.9.1 NovaDel Pharma Company Information
13.9.2 NovaDel Pharma GABA Receptor Agonist Drug Product Offered
13.9.3 NovaDel Pharma GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 NovaDel Pharma Main Business Overview
13.9.5 NovaDel Pharma Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis GABA Receptor Agonist Drug Product Offered
13.10.3 Novartis GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 OVATION Pharmaceuticals
13.11.1 OVATION Pharmaceuticals Company Information
13.11.2 OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Offered
13.11.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 OVATION Pharmaceuticals Main Business Overview
13.11.5 OVATION Pharmaceuticals Latest Developments
13.12 Osmotica Pharmaceutical
13.12.1 Osmotica Pharmaceutical Company Information
13.12.2 Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Offered
13.12.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Osmotica Pharmaceutical Main Business Overview
13.12.5 Osmotica Pharmaceutical Latest Developments
13.13 Pfizer
13.13.1 Pfizer Company Information
13.13.2 Pfizer GABA Receptor Agonist Drug Product Offered
13.13.3 Pfizer GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Pfizer Main Business Overview
13.13.5 Pfizer Latest Developments
13.14 sanofi-aventis
13.14.1 sanofi-aventis Company Information
13.14.2 sanofi-aventis GABA Receptor Agonist Drug Product Offered
13.14.3 sanofi-aventis GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 sanofi-aventis Main Business Overview
13.14.5 sanofi-aventis Latest Developments
13.15 VIVUS
13.15.1 VIVUS Company Information
13.15.2 VIVUS GABA Receptor Agonist Drug Product Offered
13.15.3 VIVUS GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 VIVUS Main Business Overview
13.15.5 VIVUS Latest Developments
13.16 XenoPort
13.16.1 XenoPort Company Information
13.16.2 XenoPort GABA Receptor Agonist Drug Product Offered
13.16.3 XenoPort GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 XenoPort Main Business Overview
13.16.5 XenoPort Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. GABA Receptor Agonist Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. GABA Receptor Agonist Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Bamaluzole
Table 4. Major Players of Phenibut
Table 5. Major Players of Baclofen
Table 6. Major Players of Gaboxadol
Table 7. Major Players of Klonopin (clonazepam)
Table 8. Major Players of Tiagbine
Table 9. Global GABA Receptor Agonist Drug Sales by Type (2017-2022) & (K Pcs)
Table 10. Global GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)
Table 11. Global GABA Receptor Agonist Drug Revenue by Type (2017-2022) & ($ million)
Table 12. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2017-2022)
Table 13. Global GABA Receptor Agonist Drug Sale Price by Type (2017-2022) & (USD/Pcs)
Table 14. Global GABA Receptor Agonist Drug Sales by Application (2017-2022) & (K Pcs)
Table 15. Global GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)
Table 16. Global GABA Receptor Agonist Drug Revenue by Application (2017-2022)
Table 17. Global GABA Receptor Agonist Drug Revenue Market Share by Application (2017-2022)
Table 18. Global GABA Receptor Agonist Drug Sale Price by Application (2017-2022) & (USD/Pcs)
Table 19. Global GABA Receptor Agonist Drug Sales by Company (2020-2022) & (K Pcs)
Table 20. Global GABA Receptor Agonist Drug Sales Market Share by Company (2020-2022)
Table 21. Global GABA Receptor Agonist Drug Revenue by Company (2020-2022) ($ Millions)
Table 22. Global GABA Receptor Agonist Drug Revenue Market Share by Company (2020-2022)
Table 23. Global GABA Receptor Agonist Drug Sale Price by Company (2020-2022) & (USD/Pcs)
Table 24. Key Manufacturers GABA Receptor Agonist Drug Producing Area Distribution and Sales Area
Table 25. Players GABA Receptor Agonist Drug Products Offered
Table 26. GABA Receptor Agonist Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global GABA Receptor Agonist Drug Sales by Geographic Region (2017-2022) & (K Pcs)
Table 30. Global GABA Receptor Agonist Drug Sales Market Share Geographic Region (2017-2022)
Table 31. Global GABA Receptor Agonist Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global GABA Receptor Agonist Drug Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global GABA Receptor Agonist Drug Sales by Country/Region (2017-2022) & (K Pcs)
Table 34. Global GABA Receptor Agonist Drug Sales Market Share by Country/Region (2017-2022)
Table 35. Global GABA Receptor Agonist Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global GABA Receptor Agonist Drug Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas GABA Receptor Agonist Drug Sales by Country (2017-2022) & (K Pcs)
Table 38. Americas GABA Receptor Agonist Drug Sales Market Share by Country (2017-2022)
Table 39. Americas GABA Receptor Agonist Drug Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas GABA Receptor Agonist Drug Revenue Market Share by Country (2017-2022)
Table 41. Americas GABA Receptor Agonist Drug Sales by Type (2017-2022) & (K Pcs)
Table 42. Americas GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)
Table 43. Americas GABA Receptor Agonist Drug Sales by Application (2017-2022) & (K Pcs)
Table 44. Americas GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)
Table 45. APAC GABA Receptor Agonist Drug Sales by Region (2017-2022) & (K Pcs)
Table 46. APAC GABA Receptor Agonist Drug Sales Market Share by Region (2017-2022)
Table 47. APAC GABA Receptor Agonist Drug Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC GABA Receptor Agonist Drug Revenue Market Share by Region (2017-2022)
Table 49. APAC GABA Receptor Agonist Drug Sales by Type (2017-2022) & (K Pcs)
Table 50. APAC GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)
Table 51. APAC GABA Receptor Agonist Drug Sales by Application (2017-2022) & (K Pcs)
Table 52. APAC GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)
Table 53. Europe GABA Receptor Agonist Drug Sales by Country (2017-2022) & (K Pcs)
Table 54. Europe GABA Receptor Agonist Drug Sales Market Share by Country (2017-2022)
Table 55. Europe GABA Receptor Agonist Drug Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe GABA Receptor Agonist Drug Revenue Market Share by Country (2017-2022)
Table 57. Europe GABA Receptor Agonist Drug Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)
Table 59. Europe GABA Receptor Agonist Drug Sales by Application (2017-2022) & (K Pcs)
Table 60. Europe GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa GABA Receptor Agonist Drug Sales by Country (2017-2022) & (K Pcs)
Table 62. Middle East & Africa GABA Receptor Agonist Drug Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa GABA Receptor Agonist Drug Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa GABA Receptor Agonist Drug Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa GABA Receptor Agonist Drug Sales by Type (2017-2022) & (K Pcs)
Table 66. Middle East & Africa GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa GABA Receptor Agonist Drug Sales by Application (2017-2022) & (K Pcs)
Table 68. Middle East & Africa GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of GABA Receptor Agonist Drug
Table 70. Key Market Challenges & Risks of GABA Receptor Agonist Drug
Table 71. Key Industry Trends of GABA Receptor Agonist Drug
Table 72. GABA Receptor Agonist Drug Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. GABA Receptor Agonist Drug Distributors List
Table 75. GABA Receptor Agonist Drug Customer List
Table 76. Global GABA Receptor Agonist Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 77. Global GABA Receptor Agonist Drug Sales Market Forecast by Region
Table 78. Global GABA Receptor Agonist Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global GABA Receptor Agonist Drug Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas GABA Receptor Agonist Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Americas GABA Receptor Agonist Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC GABA Receptor Agonist Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 83. APAC GABA Receptor Agonist Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe GABA Receptor Agonist Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Europe GABA Receptor Agonist Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa GABA Receptor Agonist Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 87. Middle East & Africa GABA Receptor Agonist Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global GABA Receptor Agonist Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 89. Global GABA Receptor Agonist Drug Sales Market Share Forecast by Type (2023-2028)
Table 90. Global GABA Receptor Agonist Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global GABA Receptor Agonist Drug Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global GABA Receptor Agonist Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 93. Global GABA Receptor Agonist Drug Sales Market Share Forecast by Application (2023-2028)
Table 94. Global GABA Receptor Agonist Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global GABA Receptor Agonist Drug Revenue Market Share Forecast by Application (2023-2028)
Table 96. Advicenne Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Advicenne GABA Receptor Agonist Drug Product Offered
Table 98. Advicenne GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 99. Advicenne Main Business
Table 100. Advicenne Latest Developments
Table 101. AstraZeneca Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. AstraZeneca GABA Receptor Agonist Drug Product Offered
Table 103. AstraZeneca GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 104. AstraZeneca Main Business
Table 105. AstraZeneca Latest Developments
Table 106. Athena Drug Delivery Solutions Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Offered
Table 108. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 109. Athena Drug Delivery Solutions Main Business
Table 110. Athena Drug Delivery Solutions Latest Developments
Table 111. Biocodex Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Biocodex GABA Receptor Agonist Drug Product Offered
Table 113. Biocodex GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 114. Biocodex Main Business
Table 115. Biocodex Latest Developments
Table 116. Elan Corporation Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Elan Corporation GABA Receptor Agonist Drug Product Offered
Table 118. Elan Corporation GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 119. Elan Corporation Main Business
Table 120. Elan Corporation Latest Developments
Table 121. Eli Lilly and Company Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Eli Lilly and Company GABA Receptor Agonist Drug Product Offered
Table 123. Eli Lilly and Company GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 124. Eli Lilly and Company Main Business
Table 125. Eli Lilly and Company Latest Developments
Table 126. H.LundBeck, Merck and Co Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product Offered
Table 128. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 129. H.LundBeck, Merck and Co Main Business
Table 130. H.LundBeck, Merck and Co Latest Developments
Table 131. GlaxoSmithKline Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 132. GlaxoSmithKline GABA Receptor Agonist Drug Product Offered
Table 133. GlaxoSmithKline GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 134. GlaxoSmithKline Main Business
Table 135. GlaxoSmithKline Latest Developments
Table 136. NovaDel Pharma Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 137. NovaDel Pharma GABA Receptor Agonist Drug Product Offered
Table 138. NovaDel Pharma GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 139. NovaDel Pharma Main Business
Table 140. NovaDel Pharma Latest Developments
Table 141. Novartis Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 142. Novartis GABA Receptor Agonist Drug Product Offered
Table 143. Novartis GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 144. Novartis Main Business
Table 145. Novartis Latest Developments
Table 146. OVATION Pharmaceuticals Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 147. OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Offered
Table 148. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 149. OVATION Pharmaceuticals Main Business
Table 150. OVATION Pharmaceuticals Latest Developments
Table 151. Osmotica Pharmaceutical Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 152. Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Offered
Table 153. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 154. Osmotica Pharmaceutical Main Business
Table 155. Osmotica Pharmaceutical Latest Developments
Table 156. Pfizer Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 157. Pfizer GABA Receptor Agonist Drug Product Offered
Table 158. Pfizer GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 159. Pfizer Main Business
Table 160. Pfizer Latest Developments
Table 161. sanofi-aventis Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 162. sanofi-aventis GABA Receptor Agonist Drug Product Offered
Table 163. sanofi-aventis GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 164. sanofi-aventis Main Business
Table 165. sanofi-aventis Latest Developments
Table 166. VIVUS Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 167. VIVUS GABA Receptor Agonist Drug Product Offered
Table 168. VIVUS GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 169. VIVUS Main Business
Table 170. VIVUS Latest Developments
Table 171. XenoPort Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 172. XenoPort GABA Receptor Agonist Drug Product Offered
Table 173. XenoPort GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 174. XenoPort Main Business
Table 175. XenoPort Latest Developments
Table 1. GABA Receptor Agonist Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. GABA Receptor Agonist Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Bamaluzole
Table 4. Major Players of Phenibut
Table 5. Major Players of Baclofen
Table 6. Major Players of Gaboxadol
Table 7. Major Players of Klonopin (clonazepam)
Table 8. Major Players of Tiagbine
Table 9. Global GABA Receptor Agonist Drug Sales by Type (2017-2022) & (K Pcs)
Table 10. Global GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)
Table 11. Global GABA Receptor Agonist Drug Revenue by Type (2017-2022) & ($ million)
Table 12. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2017-2022)
Table 13. Global GABA Receptor Agonist Drug Sale Price by Type (2017-2022) & (USD/Pcs)
Table 14. Global GABA Receptor Agonist Drug Sales by Application (2017-2022) & (K Pcs)
Table 15. Global GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)
Table 16. Global GABA Receptor Agonist Drug Revenue by Application (2017-2022)
Table 17. Global GABA Receptor Agonist Drug Revenue Market Share by Application (2017-2022)
Table 18. Global GABA Receptor Agonist Drug Sale Price by Application (2017-2022) & (USD/Pcs)
Table 19. Global GABA Receptor Agonist Drug Sales by Company (2020-2022) & (K Pcs)
Table 20. Global GABA Receptor Agonist Drug Sales Market Share by Company (2020-2022)
Table 21. Global GABA Receptor Agonist Drug Revenue by Company (2020-2022) ($ Millions)
Table 22. Global GABA Receptor Agonist Drug Revenue Market Share by Company (2020-2022)
Table 23. Global GABA Receptor Agonist Drug Sale Price by Company (2020-2022) & (USD/Pcs)
Table 24. Key Manufacturers GABA Receptor Agonist Drug Producing Area Distribution and Sales Area
Table 25. Players GABA Receptor Agonist Drug Products Offered
Table 26. GABA Receptor Agonist Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global GABA Receptor Agonist Drug Sales by Geographic Region (2017-2022) & (K Pcs)
Table 30. Global GABA Receptor Agonist Drug Sales Market Share Geographic Region (2017-2022)
Table 31. Global GABA Receptor Agonist Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global GABA Receptor Agonist Drug Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global GABA Receptor Agonist Drug Sales by Country/Region (2017-2022) & (K Pcs)
Table 34. Global GABA Receptor Agonist Drug Sales Market Share by Country/Region (2017-2022)
Table 35. Global GABA Receptor Agonist Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global GABA Receptor Agonist Drug Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas GABA Receptor Agonist Drug Sales by Country (2017-2022) & (K Pcs)
Table 38. Americas GABA Receptor Agonist Drug Sales Market Share by Country (2017-2022)
Table 39. Americas GABA Receptor Agonist Drug Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas GABA Receptor Agonist Drug Revenue Market Share by Country (2017-2022)
Table 41. Americas GABA Receptor Agonist Drug Sales by Type (2017-2022) & (K Pcs)
Table 42. Americas GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)
Table 43. Americas GABA Receptor Agonist Drug Sales by Application (2017-2022) & (K Pcs)
Table 44. Americas GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)
Table 45. APAC GABA Receptor Agonist Drug Sales by Region (2017-2022) & (K Pcs)
Table 46. APAC GABA Receptor Agonist Drug Sales Market Share by Region (2017-2022)
Table 47. APAC GABA Receptor Agonist Drug Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC GABA Receptor Agonist Drug Revenue Market Share by Region (2017-2022)
Table 49. APAC GABA Receptor Agonist Drug Sales by Type (2017-2022) & (K Pcs)
Table 50. APAC GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)
Table 51. APAC GABA Receptor Agonist Drug Sales by Application (2017-2022) & (K Pcs)
Table 52. APAC GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)
Table 53. Europe GABA Receptor Agonist Drug Sales by Country (2017-2022) & (K Pcs)
Table 54. Europe GABA Receptor Agonist Drug Sales Market Share by Country (2017-2022)
Table 55. Europe GABA Receptor Agonist Drug Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe GABA Receptor Agonist Drug Revenue Market Share by Country (2017-2022)
Table 57. Europe GABA Receptor Agonist Drug Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)
Table 59. Europe GABA Receptor Agonist Drug Sales by Application (2017-2022) & (K Pcs)
Table 60. Europe GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa GABA Receptor Agonist Drug Sales by Country (2017-2022) & (K Pcs)
Table 62. Middle East & Africa GABA Receptor Agonist Drug Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa GABA Receptor Agonist Drug Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa GABA Receptor Agonist Drug Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa GABA Receptor Agonist Drug Sales by Type (2017-2022) & (K Pcs)
Table 66. Middle East & Africa GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa GABA Receptor Agonist Drug Sales by Application (2017-2022) & (K Pcs)
Table 68. Middle East & Africa GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of GABA Receptor Agonist Drug
Table 70. Key Market Challenges & Risks of GABA Receptor Agonist Drug
Table 71. Key Industry Trends of GABA Receptor Agonist Drug
Table 72. GABA Receptor Agonist Drug Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. GABA Receptor Agonist Drug Distributors List
Table 75. GABA Receptor Agonist Drug Customer List
Table 76. Global GABA Receptor Agonist Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 77. Global GABA Receptor Agonist Drug Sales Market Forecast by Region
Table 78. Global GABA Receptor Agonist Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global GABA Receptor Agonist Drug Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas GABA Receptor Agonist Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Americas GABA Receptor Agonist Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC GABA Receptor Agonist Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 83. APAC GABA Receptor Agonist Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe GABA Receptor Agonist Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Europe GABA Receptor Agonist Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa GABA Receptor Agonist Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 87. Middle East & Africa GABA Receptor Agonist Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global GABA Receptor Agonist Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 89. Global GABA Receptor Agonist Drug Sales Market Share Forecast by Type (2023-2028)
Table 90. Global GABA Receptor Agonist Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global GABA Receptor Agonist Drug Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global GABA Receptor Agonist Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 93. Global GABA Receptor Agonist Drug Sales Market Share Forecast by Application (2023-2028)
Table 94. Global GABA Receptor Agonist Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global GABA Receptor Agonist Drug Revenue Market Share Forecast by Application (2023-2028)
Table 96. Advicenne Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Advicenne GABA Receptor Agonist Drug Product Offered
Table 98. Advicenne GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 99. Advicenne Main Business
Table 100. Advicenne Latest Developments
Table 101. AstraZeneca Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. AstraZeneca GABA Receptor Agonist Drug Product Offered
Table 103. AstraZeneca GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 104. AstraZeneca Main Business
Table 105. AstraZeneca Latest Developments
Table 106. Athena Drug Delivery Solutions Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Offered
Table 108. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 109. Athena Drug Delivery Solutions Main Business
Table 110. Athena Drug Delivery Solutions Latest Developments
Table 111. Biocodex Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Biocodex GABA Receptor Agonist Drug Product Offered
Table 113. Biocodex GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 114. Biocodex Main Business
Table 115. Biocodex Latest Developments
Table 116. Elan Corporation Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Elan Corporation GABA Receptor Agonist Drug Product Offered
Table 118. Elan Corporation GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 119. Elan Corporation Main Business
Table 120. Elan Corporation Latest Developments
Table 121. Eli Lilly and Company Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Eli Lilly and Company GABA Receptor Agonist Drug Product Offered
Table 123. Eli Lilly and Company GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 124. Eli Lilly and Company Main Business
Table 125. Eli Lilly and Company Latest Developments
Table 126. H.LundBeck, Merck and Co Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product Offered
Table 128. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 129. H.LundBeck, Merck and Co Main Business
Table 130. H.LundBeck, Merck and Co Latest Developments
Table 131. GlaxoSmithKline Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 132. GlaxoSmithKline GABA Receptor Agonist Drug Product Offered
Table 133. GlaxoSmithKline GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 134. GlaxoSmithKline Main Business
Table 135. GlaxoSmithKline Latest Developments
Table 136. NovaDel Pharma Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 137. NovaDel Pharma GABA Receptor Agonist Drug Product Offered
Table 138. NovaDel Pharma GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 139. NovaDel Pharma Main Business
Table 140. NovaDel Pharma Latest Developments
Table 141. Novartis Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 142. Novartis GABA Receptor Agonist Drug Product Offered
Table 143. Novartis GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 144. Novartis Main Business
Table 145. Novartis Latest Developments
Table 146. OVATION Pharmaceuticals Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 147. OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Offered
Table 148. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 149. OVATION Pharmaceuticals Main Business
Table 150. OVATION Pharmaceuticals Latest Developments
Table 151. Osmotica Pharmaceutical Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 152. Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Offered
Table 153. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 154. Osmotica Pharmaceutical Main Business
Table 155. Osmotica Pharmaceutical Latest Developments
Table 156. Pfizer Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 157. Pfizer GABA Receptor Agonist Drug Product Offered
Table 158. Pfizer GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 159. Pfizer Main Business
Table 160. Pfizer Latest Developments
Table 161. sanofi-aventis Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 162. sanofi-aventis GABA Receptor Agonist Drug Product Offered
Table 163. sanofi-aventis GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 164. sanofi-aventis Main Business
Table 165. sanofi-aventis Latest Developments
Table 166. VIVUS Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 167. VIVUS GABA Receptor Agonist Drug Product Offered
Table 168. VIVUS GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 169. VIVUS Main Business
Table 170. VIVUS Latest Developments
Table 171. XenoPort Basic Information, GABA Receptor Agonist Drug Manufacturing Base, Sales Area and Its Competitors
Table 172. XenoPort GABA Receptor Agonist Drug Product Offered
Table 173. XenoPort GABA Receptor Agonist Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 174. XenoPort Main Business
Table 175. XenoPort Latest Developments
LIST OF FIGURES
Figure 1. Picture of GABA Receptor Agonist Drug
Figure 2. GABA Receptor Agonist Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GABA Receptor Agonist Drug Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global GABA Receptor Agonist Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. GABA Receptor Agonist Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Bamaluzole
Figure 10. Product Picture of Phenibut
Figure 11. Product Picture of Baclofen
Figure 12. Product Picture of Gaboxadol
Figure 13. Product Picture of Klonopin (clonazepam)
Figure 14. Product Picture of Tiagbine
Figure 15. Global GABA Receptor Agonist Drug Sales Market Share by Type in 2021
Figure 16. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2017-2022)
Figure 17. GABA Receptor Agonist Drug Consumed in Attention Deficit Hyperactivity Disorder (ADHD)
Figure 18. Global GABA Receptor Agonist Drug Market: Attention Deficit Hyperactivity Disorder (ADHD) (2017-2022) & (K Pcs)
Figure 19. GABA Receptor Agonist Drug Consumed in Psychiatric Disorders and Depression
Figure 20. Global GABA Receptor Agonist Drug Market: Psychiatric Disorders and Depression (2017-2022) & (K Pcs)
Figure 21. GABA Receptor Agonist Drug Consumed in Alzheimer
Figure 22. Global GABA Receptor Agonist Drug Market: Alzheimer (2017-2022) & (K Pcs)
Figure 23. GABA Receptor Agonist Drug Consumed in Epilepsy and Seizure
Figure 24. Global GABA Receptor Agonist Drug Market: Epilepsy and Seizure (2017-2022) & (K Pcs)
Figure 25. GABA Receptor Agonist Drug Consumed in Anxiety and Sleep Disorders
Figure 26. Global GABA Receptor Agonist Drug Market: Anxiety and Sleep Disorders (2017-2022) & (K Pcs)
Figure 27. GABA Receptor Agonist Drug Consumed in Obesity and Alcoholism
Figure 28. Global GABA Receptor Agonist Drug Market: Obesity and Alcoholism (2017-2022) & (K Pcs)
Figure 29. Global GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)
Figure 30. Global GABA Receptor Agonist Drug Revenue Market Share by Application in 2021
Figure 31. GABA Receptor Agonist Drug Revenue Market by Company in 2021 ($ Million)
Figure 32. Global GABA Receptor Agonist Drug Revenue Market Share by Company in 2021
Figure 33. Global GABA Receptor Agonist Drug Sales Market Share by Geographic Region (2017-2022)
Figure 34. Global GABA Receptor Agonist Drug Revenue Market Share by Geographic Region in 2021
Figure 35. Global GABA Receptor Agonist Drug Sales Market Share by Region (2017-2022)
Figure 36. Global GABA Receptor Agonist Drug Revenue Market Share by Country/Region in 2021
Figure 37. Americas GABA Receptor Agonist Drug Sales 2017-2022 (K Pcs)
Figure 38. Americas GABA Receptor Agonist Drug Revenue 2017-2022 ($ Millions)
Figure 39. APAC GABA Receptor Agonist Drug Sales 2017-2022 (K Pcs)
Figure 40. APAC GABA Receptor Agonist Drug Revenue 2017-2022 ($ Millions)
Figure 41. Europe GABA Receptor Agonist Drug Sales 2017-2022 (K Pcs)
Figure 42. Europe GABA Receptor Agonist Drug Revenue 2017-2022 ($ Millions)
Figure 43. Middle East & Africa GABA Receptor Agonist Drug Sales 2017-2022 (K Pcs)
Figure 44. Middle East & Africa GABA Receptor Agonist Drug Revenue 2017-2022 ($ Millions)
Figure 45. Americas GABA Receptor Agonist Drug Sales Market Share by Country in 2021
Figure 46. Americas GABA Receptor Agonist Drug Revenue Market Share by Country in 2021
Figure 47. United States GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. Canada GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Mexico GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. Brazil GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. APAC GABA Receptor Agonist Drug Sales Market Share by Region in 2021
Figure 52. APAC GABA Receptor Agonist Drug Revenue Market Share by Regions in 2021
Figure 53. China GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Japan GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. South Korea GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. Southeast Asia GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. India GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Australia GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Europe GABA Receptor Agonist Drug Sales Market Share by Country in 2021
Figure 60. Europe GABA Receptor Agonist Drug Revenue Market Share by Country in 2021
Figure 61. Germany GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. France GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. UK GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. Italy GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Russia GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Middle East & Africa GABA Receptor Agonist Drug Sales Market Share by Country in 2021
Figure 67. Middle East & Africa GABA Receptor Agonist Drug Revenue Market Share by Country in 2021
Figure 68. Egypt GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 69. South Africa GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 70. Israel GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 71. Turkey GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 72. GCC Country GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of GABA Receptor Agonist Drug in 2021
Figure 74. Manufacturing Process Analysis of GABA Receptor Agonist Drug
Figure 75. Industry Chain Structure of GABA Receptor Agonist Drug
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 1. Picture of GABA Receptor Agonist Drug
Figure 2. GABA Receptor Agonist Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GABA Receptor Agonist Drug Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global GABA Receptor Agonist Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. GABA Receptor Agonist Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Bamaluzole
Figure 10. Product Picture of Phenibut
Figure 11. Product Picture of Baclofen
Figure 12. Product Picture of Gaboxadol
Figure 13. Product Picture of Klonopin (clonazepam)
Figure 14. Product Picture of Tiagbine
Figure 15. Global GABA Receptor Agonist Drug Sales Market Share by Type in 2021
Figure 16. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2017-2022)
Figure 17. GABA Receptor Agonist Drug Consumed in Attention Deficit Hyperactivity Disorder (ADHD)
Figure 18. Global GABA Receptor Agonist Drug Market: Attention Deficit Hyperactivity Disorder (ADHD) (2017-2022) & (K Pcs)
Figure 19. GABA Receptor Agonist Drug Consumed in Psychiatric Disorders and Depression
Figure 20. Global GABA Receptor Agonist Drug Market: Psychiatric Disorders and Depression (2017-2022) & (K Pcs)
Figure 21. GABA Receptor Agonist Drug Consumed in Alzheimer
Figure 22. Global GABA Receptor Agonist Drug Market: Alzheimer (2017-2022) & (K Pcs)
Figure 23. GABA Receptor Agonist Drug Consumed in Epilepsy and Seizure
Figure 24. Global GABA Receptor Agonist Drug Market: Epilepsy and Seizure (2017-2022) & (K Pcs)
Figure 25. GABA Receptor Agonist Drug Consumed in Anxiety and Sleep Disorders
Figure 26. Global GABA Receptor Agonist Drug Market: Anxiety and Sleep Disorders (2017-2022) & (K Pcs)
Figure 27. GABA Receptor Agonist Drug Consumed in Obesity and Alcoholism
Figure 28. Global GABA Receptor Agonist Drug Market: Obesity and Alcoholism (2017-2022) & (K Pcs)
Figure 29. Global GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)
Figure 30. Global GABA Receptor Agonist Drug Revenue Market Share by Application in 2021
Figure 31. GABA Receptor Agonist Drug Revenue Market by Company in 2021 ($ Million)
Figure 32. Global GABA Receptor Agonist Drug Revenue Market Share by Company in 2021
Figure 33. Global GABA Receptor Agonist Drug Sales Market Share by Geographic Region (2017-2022)
Figure 34. Global GABA Receptor Agonist Drug Revenue Market Share by Geographic Region in 2021
Figure 35. Global GABA Receptor Agonist Drug Sales Market Share by Region (2017-2022)
Figure 36. Global GABA Receptor Agonist Drug Revenue Market Share by Country/Region in 2021
Figure 37. Americas GABA Receptor Agonist Drug Sales 2017-2022 (K Pcs)
Figure 38. Americas GABA Receptor Agonist Drug Revenue 2017-2022 ($ Millions)
Figure 39. APAC GABA Receptor Agonist Drug Sales 2017-2022 (K Pcs)
Figure 40. APAC GABA Receptor Agonist Drug Revenue 2017-2022 ($ Millions)
Figure 41. Europe GABA Receptor Agonist Drug Sales 2017-2022 (K Pcs)
Figure 42. Europe GABA Receptor Agonist Drug Revenue 2017-2022 ($ Millions)
Figure 43. Middle East & Africa GABA Receptor Agonist Drug Sales 2017-2022 (K Pcs)
Figure 44. Middle East & Africa GABA Receptor Agonist Drug Revenue 2017-2022 ($ Millions)
Figure 45. Americas GABA Receptor Agonist Drug Sales Market Share by Country in 2021
Figure 46. Americas GABA Receptor Agonist Drug Revenue Market Share by Country in 2021
Figure 47. United States GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. Canada GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Mexico GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. Brazil GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. APAC GABA Receptor Agonist Drug Sales Market Share by Region in 2021
Figure 52. APAC GABA Receptor Agonist Drug Revenue Market Share by Regions in 2021
Figure 53. China GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Japan GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. South Korea GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. Southeast Asia GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. India GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Australia GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Europe GABA Receptor Agonist Drug Sales Market Share by Country in 2021
Figure 60. Europe GABA Receptor Agonist Drug Revenue Market Share by Country in 2021
Figure 61. Germany GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. France GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. UK GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. Italy GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Russia GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Middle East & Africa GABA Receptor Agonist Drug Sales Market Share by Country in 2021
Figure 67. Middle East & Africa GABA Receptor Agonist Drug Revenue Market Share by Country in 2021
Figure 68. Egypt GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 69. South Africa GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 70. Israel GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 71. Turkey GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 72. GCC Country GABA Receptor Agonist Drug Revenue Growth 2017-2022 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of GABA Receptor Agonist Drug in 2021
Figure 74. Manufacturing Process Analysis of GABA Receptor Agonist Drug
Figure 75. Industry Chain Structure of GABA Receptor Agonist Drug
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
